Post-operative Pain Management Market Research Report - Forecast to 2027

Post-operative pain management market research report, by pain type (acute pain, moderate pain, and severe pain), by products (non-steroidal anti-inflammatory drugs, antiepileptic drugs, opioids), application (cancer pain, arthritic pain, neuropathic pain, musculoskeletal pain, migraine, and other), by target area (back, legs, hand and arms and other) - forecast to 2027

ID: MRFR/Pharma/0738-HCR | February 2021 | Region: Global | 80 pages

Post-operative Pain Management Market Overview


Post-operative pain management market growth is expected to rise by 5.4% by 2023. All the surgeries have some kind of post-operative pain. However, the pain management market will minimize the pain associated with surgeries. This post-surgery pain can be unbearable at times. It can lead to psychological issues and other problems in individuals. The demand for this market is constantly surging in the forecast period. It is a market providing treatment that can soothe and ease the pain of patients.


Various anti-inflammatory drugs are prescribed for the patients. There is a wide range of clinical drugs in the post-operative pain management market. Non-steroids drugs, anesthesia, inhibitors and opioid are some of the drugs in Post-operative pain management market. All these treatments are provided for patients orally and through injection. The continuous growth of the Post-operative pain management market will continue in the upcoming years.


Also, new cases of chronic illnesses and surgeries are growing every year. These factors lead to high demand for pain management. It is a market with a wide range of treatments and drugs. Cost-effectiveness of pain management drugs leads to higher adoption in hostiles. As per post-operative pain management market analysis these factors will drive immense demand.


Covid analysis 


The pandemic is affecting operations of the global market in various domains. The outbreak of covid 19 is bringing a few challenges in the post postoperative pain management industry. Also, Covid 19 is causing much burden on the healthcare sector. The pain management drugs are operating for only covid patients. Due to the covid 19, the number of surgeries in hospitals has reduced. Even for chronic illness such as heart disease, kidney problems and another illness number of surgeries have reduced. 


Most of the hospitals give more importance covid patient care. Treatments with social distancing are allowed by the government. Only emergency surgeries are taking place. Also, the post-operative pain management market is witnessing a decline in demand rate during this period. The surgeries for chronic illness are extremely low leading to less growth. The international anesthesia journal, says that covid 19 has a damaging impact on postoperative pain management. However, post covid 19, scenarios of the market remains positive. 


Post-operative Pain Management Market dynamics 



  • Crucial market drivers 


The rising demand for pain management drugs is a demand driving factor of the Post-operative pain management market. As per the national health statistics, 100 million surgeries take place in the US. The surging rate of surgeries in many regions is a reason for high pain management drugs. Worldwide the rate of cancer surgeries is growing. These surgeries all over the world are raising the need for pain drugs and treatment. Furthermore, pediatric and ageing population surgeries are leading to high postoperative pain therapeutics market growth. The healing process of these surgeries is slow.


Especially, the senior population is prone to chronic illness. The recovery time from these surgeries is prolonged. It can make the patient tolerate pain for a longer time. During these situations, various high dose and mild dose pain management drugs are administered. These growth factors of the Post-operative pain management market will bring a high expansion rate for the market. Further, the rising awareness of surgeries is another crucial driver of the market.


Today, many patients suffer from bouts of chronic illnesses. The only way to treat some of this disease is through surgeries. Therefore, most of the patient population is opting for quality surgeries. Also, many patients opt for surgeries due to effective pain management drugs prescribed by physicians. All these market drivers will bring favourable changes in the market. 



  • Market growth opportunities 


The rise of road accidents and traumas will lead to exceptional market growth opportunities. In upcoming years, road accidents are expected to surge. Due to more number of vehicles on road is a key reason for these accidents. Also, many individuals do not take road rules seriously. all these factors are exceeding raise the accidents on-road. These accidents can have brutal injuries on individuals. Also, pain related to accidents is unbearable.


There are patient’s death rates due to high pain due to these incidents. However, postoperative pain management is helpful to manage heavy pain and soreness. The availability of pain medications will be higher for such road accidents. The key players are increasing their production due to these factors. These factors will lead to positive growth in the post-operative pain management market.


Furthermore, the high research and development activities in the market will bring high growth possibilities. Recently the demand for non-narcotic drugs has a high demand. Most hospitals prefer these non-narcotic drugs as they have fewer side effects. Also, recovery is safe and quick with these medicines. These factors will expand the overall post-operative pain management market. 



  • The market restraints 


Pain management drugs are beneficial to manage any kind of surgery pain. The adoption of these drugs is tremendous. Few factors hinder the adoption rate of this market. The side effects after the administration of pain management medications are restraining the Post-operative pain management market growth. 


The side effects of these medications are comparatively low than other treatments. However, infection is serious restraint. Especially, the overdose of analgesic post-operative pain medication is leading to high death rates. These medications are not suitable for most patients. These factors limit the decline and patient interest to choose these devices. 



  • The market challenges 


The stringent governmental rules for the post-operative pain management market are a challenge. Most of the pain medications do not pass the approval of the government. The entire process to get such approval is prolonged.


The research, clinical trials and production and supply of these medications is delayed due to these stringent rules. The key players in the market are making plenty of product developments. All these factors will lead to new lunches in the market. However, with the stringent rules, the growth is affected. 



  • Cumulative growth analysis 


Pain management industry analysis shows a surging growth trend. There are plenty of growth factors in the market. The rising rate of surgeries in the US and other developing regions will contribute to high growth. Also, the non-medical segment of the market will witness rapid growth.


Many hospitals and clinics prefer non-medical pain medications to analgesics. However, the side effects of the treatment are a drawback of this market. They need users try other alternatives due to the fear of side effects. Also, stringent rules remain a problem for this market. The overall growth rate of the market is substantial due to promising growth opportunities. 



  • Value chain analysis 


Geographically, North America dominates the overall post-operative pain management market. It is a region that marks a higher number does surgeries in a year. Chronic illness is the major factor for many surgeries. Also, the awareness about quality surgeries for chronic illness is high among patients.


Due to this, the adoption of pain medication is higher. Further, the investments in US and Canada are high for Post-operative pain management market. New drug developments, innovations and expansion will rise in the market. The favourable market scenarios in North America will contribute to high demand in the forecast period. 


Segment overview 


By product 



  • Antiseptic drugs 

  • Non-steroid inflammatory drugs 

  • Opioid 


By distribution channel 



  • Clinics 

  • Retail pharmacies 

  • Hospital 


by geography 



  • Europe 

  • Asia pacific 

  • North America 

  • The Middle East and Africa 


Competitive landscape 


The competition is severe in the post-operative pain management market is increasing. During the forecast period, there are various developments in the market. Crucial strategy in the competitive landscape is acquisition, expansion and partnerships are part of the competitive landscape. The rising investments for non-narcoleptic pain drugs will be high. it will lead to new product launches of non-medical pain drugs. 


Regional analysis 


Post-operative pain management is diversified into Asia Pacific, Europe and North America. North America is a leading market that supplies more than 54.1 million pain drugs. the increase in the senior population is leading to the number of safe surgeries is increasing the reliability of patients. Due to this, many are proffering surgeries for chronic illness.


Europe is the next largest post-operative pain management market. The availability of pain drugs and treatment is a wide range. The Asia Pacific is a region known for its safety and quality post-operative pain management market. The medications available here are of high quality. Also, cost-effective postoperative treatment is available in the region. 


The key players of the post-operative pain management market are 



  1. Janssen Pharmaceuticals

  2. Pacira

  3. Pharmaceuticals Inc

  4. Purdue Pharma L.P

  5. Egalet Corporation

  6. GlaxoSmithKline Plc

  7. Pharmaceutical Industries Ltd

  8. Allergan plc

  9. Novartis AG

  10. Pfizer Inc

  11. Endo International plc


Recent developments 



  1. The production of non-steroid drugs is rising in many regions. the developed regions are first to increase production. 



  1. The emerging economies will have high scope for postoperative pain management drugs. middle east and Africa is key emerging market.


Report overview 



  1. Market overview highlights 

  2. Analysis based upon COVID 19

  3. Explanation upon the Market Dynamics

  4. Value chain analysis

  5. Market segmentation overview

  6. The regional analysis

  7. Competitive landscape analysis

  8. Recent Developments



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   5.4% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   pain type, products, application and target area
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly (U.S), Pfizer (U.S), Johnson & Johnson (U.S), Purdue Pharma (U.S), Endo Pharmaceuticals Plc. (U.S), Forest Laboratories Inc. (U.S), GlaxoSmithKline Plc. (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter International Inc. (US), Valeant Pharmaceuticals International Inc. (Canada)
  Key Market Opportunities   Rising prevalence of different diseases across the globe
  Key Market Drivers

  • Increasing demand for the pain control drugs and devices
  • Increasing aging population is also has a synergistic impact of the growth


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The post-operative pain management market is estimated to grow at 5.4% CAGR during the forecast period (2017-2023).

    Increase in the global economy that is widening the access to the quality healthcare.

    North America holds the largest share in the global post-operative pain management market followed by Europe and Asia Pacific, respectively.

    Eli Lilly Company (US), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer (US), Purdue Pharma (US), Johnson & Johnson (US), Endo Pharmaceuticals Plc. (US), GlaxoSmithKline Plc. (UK), Forest Laboratories Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Valeant Pharmaceuticals International Inc. (Canada), and Baxter International Inc. (US), are some of the major players operating in the global post-operative pain management market.

    Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global post-operative pain management market adopt to gain a larger competitive advantage.

    1 Introduction

    1.1 Definition

    1.2 Scope Of Study

    1.2.1 Research Objective

    1.2.2 Assumptions & Limitations

    1.2.2.1 Assumptions

    1.2.2.2 Limitations

    1.3 Market Structure:

    2 Research Methodology

    2.1 Research Process:

    2.2 Primary Research

    2.3 Secondary Research:

    3 Market Dynamics

    3.1 Drivers

    3.2 Restraints

    3.3 Opportunities

    3.4 Macroeconomic Indicators

    4 Market Factor Analysis

    4.1 Porters Five Forces Model

    4.2 Bargaining Power Of Suppliers

    4.3 Bargaining Power Of Buyers

    4.4 Threat Of New Entrants

    4.5 Threat Of Substitutes

    4.6 Intensity Of Rivalry

    5. Global Post-Operative Pain Management Market, By Pain Type

    5.1 Acute Pain

    5.2 Moderate Pain

    5.3 Severe Pain

    6. Global Post-Operative Pain Management Market, By Product

    6.1 Non-Steroidal Anti-Inflammatory Drugs (Nsaids)

    6.2 Antiepileptic Drugs

    6.3 Cox-2 Inhibitors

    6.4 Opioids

    6.5 Other Analgesics

    7. Global Post-Operative Pain Management Market, By Application

    7.1 Cancer Pain

    7.2 Arthritic Pain

    7.3 Neuropathic Pain

    7.4 Musculoskeletal Pain

    7.5 Migraine

    7.6 Other

    8. Global Post-Operative Pain Management Market, By Target Area

    8.1 Back

    8.2 Legs

    8.3 Hand and Arms

    8.4 Other

    9. Global Post-Operative Pain Management Market, By Region

    9.1 Introduction

    9.2 America

    9.2.1 North America

    9.2.1.1 US

    9.2.1.1 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.3 Spain

    9.3.1.5 UK

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic Of Korea

    9.4.6 Rest of Asia-Pacific

    9.5 Middle East & Africa

    9.5.1 United Arab Emirates

    9.5.2 Saudi Arabia

    9.5.3 Oman

    9.5.4 Kuwait

    9.5.5 Qatar

    9.5.6 Rest Of Middle East & Africa

    10. Competitive Landscape

    10.1 Major Strategies Adopted By Market Players

    10.1.1 Strategic Partnership

    10.1.2 Merger & Acquisition

    11 Company Profile

    11.1 Teva Pharmaceutical Industries Ltd.

    11.1.1 Overview

    11.1.2 Product Overview

    11.1.3 Financials

    11.1.4 Key Developments

    11.2 Eli Lilly

    11.2.1 Overview

    11.2.2 Product Overview

    11.2.3 Financials

    11.2.4 Key Developments

    11.3 Pfizer

    11.3.1 Overview

    11.3.2 Product Overview

    11.3.3 Financials

    11.3.4 Strategy

    11.3.5 Key Development

    11.4 Johnson & Johnson

    11.4.1 Overview

    11.4.2 Product Overview

    11.4.3 Financials

    11.4.4 Key Developments

    11.5 Purdue Pharma

    11.5.1 Overview

    11.5.2 Product Overview

    11.5.3 Financials

    11.5.4 Key Developments

    11.6 Others

    11 Conclusion

    12.1 Key Findings

    12.1.1 From Ceo’s Viewpoint

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Prediction of Post-Operative Pain Management Industry

    13 Appendix